BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3198098)

  • 1. [The synthesis, animal experiments, and preliminary clinical trial of Cr (III)-nicotinic acid-amino acids mixed ligand complexes].
    Yang JC; Dai GZ; Guo JY; Yan BZ; Chen SQ; Cai SY; Cao ZR
    Hua Xi Yi Ke Da Xue Xue Bao; 1988 Jun; 19(2):167-9. PubMed ID: 3198098
    [No Abstract]   [Full Text] [Related]  

  • 2. [Arteriosclerosis--nicotinic acid therapy. 7. Effect of nicotinic acid on lipoproteins].
    Carlson LA
    Lakartidningen; 1971 Apr; 68(15):1763-4. PubMed ID: 5577249
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of nicotinic acid on muscle lipid concentration in man.
    Fröberg SO; Castenfors H
    Acta Med Scand; 1974; 196(1-2):65-7. PubMed ID: 4418517
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with SPN 40150 in hyperlipidemia and arteriosclerotic circulatory disturbances (author's transl)].
    Schimert G
    MMW Munch Med Wochenschr; 1974 Feb; 116(8):389-92. PubMed ID: 4208098
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arteriosclerosis--nicotinic acid therapy. 6. Treatment of hyperlipemia].
    Orö L
    Lakartidningen; 1971 Apr; 68(15):1758-62. PubMed ID: 5577248
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
    Dimroth H
    Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of hyperlipemias with lipolytic drugs].
    Jover Sanz E; Paradinas Jiménez C; Corporales López L; Martínez Robles JV
    Rev Clin Esp; 1974 Jun; 133(5):447-50. PubMed ID: 4428087
    [No Abstract]   [Full Text] [Related]  

  • 8. [Arteriosclerosis--nicotinic acid therapy. 10. Combination therapy in hyperlipemia].
    Hansen PF
    Lakartidningen; 1971 Apr; 68(15):1769-72. PubMed ID: 5577252
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arteriosclerosis--nicotinic acid therapy. 2. Alterations in serum lipoproteins. Diagnosis, therapy].
    Gustafson A
    Lakartidningen; 1971 Apr; 68(15):1744-5 passim. PubMed ID: 5577244
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs.
    Lundholm L; Jacobsson L; Brattsand R; Magnusson O
    Atherosclerosis; 1978 Feb; 29(2):217-39. PubMed ID: 646851
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
    Sterner W; Schultz A
    Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
    [No Abstract]   [Full Text] [Related]  

  • 12. The therapeutic potential of glucose tolerance factor.
    McCarty MF
    Med Hypotheses; 1980 Nov; 6(11):1177-89. PubMed ID: 7005627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT
    Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of nicotinic acid on the diurnal variation of the free fatty acids of plasma.
    Carlström S; Laurell S
    Acta Med Scand; 1968; 184(1-2):121-3. PubMed ID: 5317782
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of treatment with nicotinic acid for one month on serum lipids in patients with different types of hyperlipidemia.
    Carlson LA; Orö L
    Atherosclerosis; 1973; 18(1):1-9. PubMed ID: 4126332
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of organic bound chrome in disturbed glycoregulation therapy.
    Djordjević PB; Dimitrijević V; Maksimović R; Vrvić M; Vucetić J
    Transplant Proc; 1995 Dec; 27(6):3333-4. PubMed ID: 8539976
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: Lipid-lowering drugs after myocardial infarction.
    Lancet; 1975 Mar; 1(7905):501-2. PubMed ID: 46964
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of hyperlipidemia.
    Levy RI; Morganroth J; Rifkind BM
    N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of nicotinic acid upon the disturbances in lipid metabolism caused by carbon disulphide in rats.
    Wrońska-Nofer T
    Int Arch Arbeitsmed; 1970; 27(3):221-7. PubMed ID: 5490373
    [No Abstract]   [Full Text] [Related]  

  • 20. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
    Levy H
    Med Klin; 1974 Sep; 69(36):1441-7. PubMed ID: 4280008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.